[go: up one dir, main page]

KEGG   DRUG: Mepolizumab
Entry
D04923                      Drug                                   
Name
Mepolizumab (USAN/INN);
Mepolizumab (genetical recombination) (JAN);
Nucala (TN)
Product
Class
Immunological agent
 DG02019  Interleukin inhibitor
Remark
Therapeutic category: 2290
ATC code: R03DX09
Product: D04923<JP/US>
Efficacy
Antiasthmatic, Anti-IL-5 antibody
  Disease
Asthma, eosinophilic phenotype [DS:H00079]
  Type
Monoclonal antibody
Target
IL5 [HSA:3567] [KO:K05428]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  JAK-STAT signaling pathway
hsa04640  Hematopoietic cell lineage
hsa04657  IL-17 signaling pathway
hsa04658  Th1 and Th2 cell differentiation
hsa04660  T cell receptor signaling pathway
hsa05310  Asthma
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 R RESPIRATORY SYSTEM
  R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
   R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
    R03DX Other systemic drugs for obstructive airway diseases
     R03DX09 Mepolizumab
      D04923  Mepolizumab (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
 Respiratory Tract/Pulmonary Agents
  Respiratory Tract Agents, Other
   Immunomodulators
    Mepolizumab
     D04923  Mepolizumab (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  22  Respiratory organ agents
   229  Miscellaneous
    2290  Miscellaneous
     D04923  Mepolizumab (USAN/INN); Mepolizumab (genetical recombination) (JAN)
Drug groups [BR:br08330]
 Immunological agent
  DG02019  Interleukin inhibitor
   D04923  Mepolizumab
Drug classes [BR:br08332]
 Immunological agent
  DG02019  Interleukin inhibitor
   D04923  Mepolizumab
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Interleukins
    IL5
     D04923  Mepolizumab (USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D04923
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D04923
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D04923
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D04923
Other DBs
CAS: 196078-29-2
PubChem: 47206675
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system